Onex Canada Asset Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Onex Canada Asset Management’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-772,905	Closed	-$5.16M	–	130
2023 Q3	$5.16M	Hold	772,905	–	–	0.4%	80
2023 Q2	$7M	Hold	772,905	–	–	0.42%	73
2023 Q1	$5.62M	Buy	772,905 +10,000	+1%	+$74.2K	0.31%	86
2022 Q4	$5.56M	Buy	+762,905	New	+$5.66M	0.31%	93

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Onex Canada Asset Management's PNT Position: Q4 2023 in Review

Onex Canada Asset Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 772,905 shares — an estimated $5.16M sold.

Onex Canada Asset Management first reported a position in PNT in Q4 2022 and held it in 4 quarters. The position peaked at $7M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Onex Canada Asset Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Onex Canada Asset Management sold 772,905 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $5.16M.
Onex Canada Asset Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2022 and held it in 4 quarters.
Onex Canada Asset Management's POINT Biopharma Global Inc. Common Stock position peaked at $7M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Onex Canada Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.